Results 21 to 30 of about 291,790 (306)

Acute kidney injury in non-critical care setting: elaboration and validation of an in-hospital death prognosis score

BMC Nephrology, 2019
Background Acute kidney injury (AKI) is still characterized by a high mortality rate. While most patients with AKI are admitted in conventional medical units, current available data are still obtained from studies designed for patients admitted in ...
Jamal Bamoulid, Hélène Philippot, Amir Kazory, Maria Yannaraki, Thomas Crepin, Bérengère Vivet, Nadège Devillard, Caroline Roubiou, Catherine Bresson-Vautrin, Jean-Marc Chalopin, Cécile Courivaud, Didier Ducloux   +11 more
doaj   +1 more source

Thrice weekly nocturnal in-centre haemodiafiltration: a 2-year experience [PDF]

, 2015
Background: Adequate control of plasma phosphate without phosphate binders is difficult to achieve on a thrice-weekly haemodialysis schedule. The use of quotidian nocturnal dialysis is effective but not practical in the in-centre setting.
Dey, V., Hair, M., Spalding, E. M.
core   +1 more source

Glycated albumin and hemoglobin A1c levels and cause-specific mortality by patients’ conditions among hemodialysis patients with diabetes: a 3-year nationwide cohort study

BMJ Open Diabetes Research & Care, 2020
Introduction Differences in mortality and cause-specific mortality rates according to glycated albumin (GA) and hemoglobin A1c (HbA1c) levels among dialysis patients with diabetes based on hypoglycemic agent use and malnutrition status remain unclear ...
Takayuki Hamano, Masanori Abe, Atsushi Wada, Kenmei Takaichi, Shigeru Nakai, Ikuto Masakane, Kosaku Nitta   +6 more
doaj   +1 more source

Extracorporeal hemoadsorption therapy as a potential therapeutic option for rapid removal of Apixaban in high risk-surgical patients: a case report

Journal of Medical Case Reports, 2023
Background Apixaban is a non-vitamin K antagonist oral anticoagulant (NOACs) recently emerged as an effective alternative to conventional vitamin K antagonists (VKAs) in the treatment of several thromboembolic disorders.
Vittorio Dalmastri, Andrea Angelini, Vera Minerva, Melissa Ballarini, Francesco Grammatico, Paola Todeschini, Attilia Maria Pizzini, Mauro Silingardi, Gaetano La Manna   +8 more
doaj   +1 more source

Telehealth: acceptability, clinical interventions and quality of life in peritoneal dialysis [PDF]

, 2016
Introduction: Telehealth technologies are being widely adopted across the globe for management of long-term conditions. There are limited data on its use, effectiveness and patient experience in end-stage renal disease.
Dey, Vishal, Jones, Audrey, Spalding, Elaine M.   +2 more
core   +3 more sources

Determinants of urgent start dialysis in a chronic kidney disease cohort followed by nephrologists

BMC Nephrology, 2023
Background The French Renal Epidemiology and Information Network (REIN) registry collect dialysis initiation context for each patient starting dialysis with a flawed definition of urgent start dialysis (USD).
Amin Tachikart, Clément Vachey, Charline Vauchy, Caroline Savet, Didier Ducloux, Cécile Courivaud   +5 more
doaj   +1 more source

Randomized control trial of prednisolone and doxycycline in patients with acute interstitial nephritis of unknown aetiology

Trials, 2023
Background Patients presenting with acute interstitial nephritis (AIN) of unknown aetiology, probably the earliest presentation of chronic kidney disease of unknown aetiology (CKDu), have been treated with oral prednisolone and doxycycline by physicians ...
Zeid Badurdeen, Neelakanthi Ratnatunga, Tilak Abeysekera, Abdul. W. M. Wazil, Premil N. Rajakrishna, Jalitha P. Thinnarachchi, Dulani D. Welagedera, Nadeeka Ratnayake, Adambarage. P. D. Alwis, Hemalika Abeysundara, Ranjith Kumarasiri, Richard Taylor, Nishantha Nanayakkara   +12 more
doaj   +1 more source

Efficacy and Safety of Etelcalcetide in Hemodialysis Patients with Moderate to Severe Secondary Hyperparathyroidism

Kidney and Dialysis, 2022
Background. Secondary hyperparathyroidism (SHPT) is a major risk factor for cardiovascular events and all-cause mortality in hemodialysis (HD) patients. The purpose of our study was to evaluate the effects and tolerability of etelcalcetide in HD patients
Paola Monciino, Lorenza Magagnoli, Eliana Fasulo, Michela Frittoli, Chiara Leotta, Hoang Nhat Pham, Andrea Stucchi, Paola Ciceri, Andrea Galassi, Mario Cozzolino   +9 more
doaj   +1 more source

Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications [PDF]

, 2016
This article reports the conclusions of the second part of a consensus expert conference on the nomenclature of renal replacement therapy (RRT) techniques currently utilized to manage acute kidney injury and other organ dysfunction syndromes in ...
Bagshaw, S. M., Balducci, A., Baldwin, I., Barbarigo, F., Bellomo, R., Bellomo, Rinaldo, Braganã³, P., Braunsky, J., Calletti, F., Cerda, J., Cerda, Jorge, Chawla, L., De Gaudio, A. Raffaele, De Rosa, S., De Rosa, Silvia, Di Somma, S., Doi, K., Dosil Rosende, P., Emmett, M., Fecondini, L., Galavotti, D., Garzotto, F., Garzotto, Francesco, Gibney, N., Goldstein, S. L., Guadagni, G., Honore, Patrick M., Honorã, P., Hoste, E., Inadome, S., Kashani, K., Katz, N., Kellum, J., Kenley, R., Kobayashi, Y., Lannoy, J., Lewington, A., Lorenzin, Anna, Mariano, F., Mccullough, P. A., Mehta, R. L., Menneguerre, J., Mettifogo, M., Neri, M., Neri, Mauro, Ostermann, M., Pani, A., Payen, Didier, Pirazzoli, P., Pohlmeier, R., Pouchoulin, D., Ricci, Z., Ricci, Zaccaria, Ronco, C., Ronco, Claudio, Rosner, M., Samoni, Sara, Seamann, M., Shaw, A., Tolwani, A., Villa, G., Villa, Gianluca, Vincent, J. L., Vincent, Jean-Louis, Wendon, J., Wendon, Julia, Zaccaria, Marta   +66 more
core   +4 more sources

Efficacy and Safety Analysis of Roxarestat in Regulating Renal Anemia in Patients on Maintenance Hemodialysis

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Objective To compare the efficacy and safety of roxarestat versus recombinant human erythropoietin (rhEPO) in the management of renal anemia in patients undergoing maintenance hemodialysis. Methods This was a prospective, open‐label, randomized controlled trial.
Lingling Chen, Junjie Zhu, Qiaonan Ge
wiley   +1 more source